AstraZeneca (LON:AZN) Receives “Sell” Rating from Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reiterated their sell rating on shares of AstraZeneca (LON:AZN – Free Report) in a report issued on Tuesday morning, MarketBeat Ratings reports. Several other brokerages have also recently weighed in on AZN. Jefferies Financial Group reaffirmed a hold rating and set a £110 ($140.94) price objective on shares of AstraZeneca in a […]
More Stories
Wall Street Review: Stock Rally Broadens as S&P 500, Nasdaq Hit New Record Highs
By Panos Mourdoukoutas Wall Street’s multi-week rally turned into an “everything rally” this week amid lower oil prices, steady bond...
FIFA Triples Price to $32,970 for Its Best Available Tickets to the World Cup Final
By The Associated Press FIFA tripled the price of its best available tickets to the World Cup final, making $32,970...
Fallout Nuka Girl: Release Date, Pricing and More
Have you ever explored the world of the Fallout video gaming series? If yes, you must have probably seen the...
US to Host New Israel–Lebanon Peace Talks
By Ryan Morgan The United States will again host a set of talks between Israeli and Lebanese delegations on May...
US Fighter Jet Disables 2 Iranian Tankers in Blockade Enforcement Action: CENTCOM
By Ryan Morgan A U.S. fighter jet fired on a pair of crude oil tankers as they attempted to bypass...
OpenAI Cofounder Greg Brockman Defends Company’s For-Profit Pivot—and His Own $30 Billion Payday
By Beige Luciano-Adams In the second week of a high-profile jury trial that could have a profound impact on the...